Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine versus fentanyl axillary plexus infusion for complex regional pain syndrome type I
2009-011123-31Phase 4Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital 12 de Octubre
- Start
- Feb 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levobupivacaine and fentanyl in Complex Regional Pain Syndrome Type 1 (CRPS-1) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital 12 de Octubre. Primary endpoints: Pain intensity on visual analog scale and Total morphine chloride consumption over 72 hours. Started Feb 2010; status: active.
02
Drugs
levobupivacainefentanyl
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2009-011123-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011123-31.